Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Malone

Showing results (81-90 of 239) with videos related to

Pageof 24
Sort By:
Current Medical Research and Opinion|March 8, 2011
Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgiaEdward P Armstrong, Daniel C Malone, Bill McCarberg, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 10, 2025
The cost-effectiveness of using vilobelimab with immunomodulators to treat severely ill mechanically ventilated patients with COVID-19: A subgroup analysis of the PANAMO studyDaniel C Malone, Roger Seheult, Diana Brixner, et al.
Journal of the American Geriatrics Society|May 17, 2011
Healthcare utilization in people with postherpetic neuralgia and painful diabetic peripheral neuropathyRobert H Dworkin, Christopher J Panarites, Edward P Armstrong, et al.
Journal of Managed Care Pharmacy : JMCP|March 31, 2009
Standardizing quality assessment of observational studies for decision making in health careDiana I Brixner, Anke-Peggy Holtorf, Peter J Neumann, et al.
The Journal of Pain|October 27, 2009
Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on health care costsRobert H Dworkin, Daniel C Malone, Christopher J Panarites, et al.
Journal of the American Pharmacists Association : Japha|May 11, 2011
Assessment tool for pharmacy drug-drug interaction softwareTerri L Warholak, Lisa E Hines, Kim R Saverno, et al.
American Journal of Pharmaceutical Education|February 21, 2012
Science of safety topic coverage in experiential education in US and Taiwan colleges and schools of pharmacyDerek H Tang, Terri L Warholak, Marion K Slack, et al.
Postgraduate Medicine|February 17, 2021
Evaluation of the cost-utility of a prescription digital therapeutic for the treatment of opioid use disorderFulton F Velez, Hilary F Luderer, Robert Gerwien, et al.
Leukemia & Lymphoma|September 14, 2023
Chimeric antigen receptor T-cell immunotherapies adverse events reported to FAERS database: focus on cytopeniasAinhoa Gomez-Lumbreras, Santiago Mercadal Vilchez, Lorenzo Villa-Zapata, et al.
American Journal of Pharmaceutical Education|September 21, 2011
Pharmacy students' retention of knowledge of drug-drug interactionsAdrienne M Gilligan, Terri L Warholak, John E Murphy, et al.
Pageof 24

Showing results (81-90 of 239) with videos related to

Sort By:
Pageof 24
Current Medical Research and Opinion|March 8, 2011
Cost-effectiveness analysis of a new 8% capsaicin patch compared to existing therapies for postherpetic neuralgiaEdward P Armstrong, Daniel C Malone, Bill McCarberg, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 10, 2025
The cost-effectiveness of using vilobelimab with immunomodulators to treat severely ill mechanically ventilated patients with COVID-19: A subgroup analysis of the PANAMO studyDaniel C Malone, Roger Seheult, Diana Brixner, et al.
Journal of the American Geriatrics Society|May 17, 2011
Healthcare utilization in people with postherpetic neuralgia and painful diabetic peripheral neuropathyRobert H Dworkin, Christopher J Panarites, Edward P Armstrong, et al.
Journal of Managed Care Pharmacy : JMCP|March 31, 2009
Standardizing quality assessment of observational studies for decision making in health careDiana I Brixner, Anke-Peggy Holtorf, Peter J Neumann, et al.
The Journal of Pain|October 27, 2009
Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on health care costsRobert H Dworkin, Daniel C Malone, Christopher J Panarites, et al.
Journal of the American Pharmacists Association : Japha|May 11, 2011
Assessment tool for pharmacy drug-drug interaction softwareTerri L Warholak, Lisa E Hines, Kim R Saverno, et al.
American Journal of Pharmaceutical Education|February 21, 2012
Science of safety topic coverage in experiential education in US and Taiwan colleges and schools of pharmacyDerek H Tang, Terri L Warholak, Marion K Slack, et al.
Postgraduate Medicine|February 17, 2021
Evaluation of the cost-utility of a prescription digital therapeutic for the treatment of opioid use disorderFulton F Velez, Hilary F Luderer, Robert Gerwien, et al.
Leukemia & Lymphoma|September 14, 2023
Chimeric antigen receptor T-cell immunotherapies adverse events reported to FAERS database: focus on cytopeniasAinhoa Gomez-Lumbreras, Santiago Mercadal Vilchez, Lorenzo Villa-Zapata, et al.
American Journal of Pharmaceutical Education|September 21, 2011
Pharmacy students' retention of knowledge of drug-drug interactionsAdrienne M Gilligan, Terri L Warholak, John E Murphy, et al.
Pageof 24